[go: up one dir, main page]

GB9711578D0 - Novel retroviral vector production systems - Google Patents

Novel retroviral vector production systems

Info

Publication number
GB9711578D0
GB9711578D0 GBGB9711578.6A GB9711578A GB9711578D0 GB 9711578 D0 GB9711578 D0 GB 9711578D0 GB 9711578 A GB9711578 A GB 9711578A GB 9711578 D0 GB9711578 D0 GB 9711578D0
Authority
GB
United Kingdom
Prior art keywords
retroviral vector
production systems
vector production
novel retroviral
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9711578.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Priority to GBGB9711578.6A priority Critical patent/GB9711578D0/en
Publication of GB9711578D0 publication Critical patent/GB9711578D0/en
Priority to JP50185799A priority patent/JP2002510204A/en
Priority to EP98925826A priority patent/EP0986649A1/en
Priority to PCT/GB1998/001626 priority patent/WO1998055640A1/en
Priority to AU77800/98A priority patent/AU741764B2/en
Priority to CA002289491A priority patent/CA2289491A1/en
Priority to CN98805788A priority patent/CN1259171A/en
Priority to KR19997011328A priority patent/KR20010013332A/en
Priority to NZ500936A priority patent/NZ500936A/en
Priority to IL13235998A priority patent/IL132359A0/en
Priority to NO995900A priority patent/NO995900L/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
GBGB9711578.6A 1997-06-04 1997-06-04 Novel retroviral vector production systems Pending GB9711578D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems
IL13235998A IL132359A0 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
AU77800/98A AU741764B2 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
EP98925826A EP0986649A1 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
PCT/GB1998/001626 WO1998055640A1 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
JP50185799A JP2002510204A (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
CA002289491A CA2289491A1 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
CN98805788A CN1259171A (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
KR19997011328A KR20010013332A (en) 1997-06-04 1998-06-04 Retro viral vector particles produced in a baculovirus expression system
NZ500936A NZ500936A (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system capable of delivering a nucleotide sequence of interest (NOI)
NO995900A NO995900L (en) 1997-06-04 1999-12-02 Retroviral vector particles formed in a baculovirus expression system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems

Publications (1)

Publication Number Publication Date
GB9711578D0 true GB9711578D0 (en) 1997-07-30

Family

ID=10813571

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9711578.6A Pending GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems

Country Status (11)

Country Link
EP (1) EP0986649A1 (en)
JP (1) JP2002510204A (en)
KR (1) KR20010013332A (en)
CN (1) CN1259171A (en)
AU (1) AU741764B2 (en)
CA (1) CA2289491A1 (en)
GB (1) GB9711578D0 (en)
IL (1) IL132359A0 (en)
NO (1) NO995900L (en)
NZ (1) NZ500936A (en)
WO (1) WO1998055640A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073424A1 (en) * 1999-05-28 2000-12-07 Mount Sinai School Of Medicine A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
US6870045B2 (en) 2000-10-23 2005-03-22 Gen-Probe Incorporated Kits for detecting HIV-2
TWI477602B (en) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
JP5309159B2 (en) * 2008-01-09 2013-10-09 コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション Vaccine using baculovirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856247T2 (en) * 1987-07-24 1999-04-29 Chiron Corp., Emeryville, Calif. BREEDING INSECT CELLS WITH AIRLIFT REACTORS
JPH03504079A (en) * 1988-03-21 1991-09-12 カイロン　コーポレイション recombinant retrovirus
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
GB9510272D0 (en) * 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors

Also Published As

Publication number Publication date
WO1998055640A1 (en) 1998-12-10
IL132359A0 (en) 2001-03-19
CN1259171A (en) 2000-07-05
AU7780098A (en) 1998-12-21
CA2289491A1 (en) 1998-12-10
NZ500936A (en) 2001-11-30
NO995900L (en) 2000-02-04
JP2002510204A (en) 2002-04-02
KR20010013332A (en) 2001-02-26
EP0986649A1 (en) 2000-03-22
NO995900D0 (en) 1999-12-02
AU741764B2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
IL136661A0 (en) Retroviral protease inhibiting compounds
AU6145998A (en) Skeletal plating system
AU134766S (en) Zipperless wetsuit
IL135343A0 (en) Novel aryloxy-alkyl-dialkylamines
SI1036083T1 (en) Novel 9a-azalides
GB9711124D0 (en) Novel cyanoguanidines
GB9506782D0 (en) Retroviral vectors
GB9711578D0 (en) Novel retroviral vector production systems
GB9711122D0 (en) Novel cyanoguanidines
GB9711127D0 (en) Novel cyanoguanidines
GB9702218D0 (en) Novel product
AU132858S (en) Wetsuit
GB2345062B (en) Retroviral vectors
GB9711523D0 (en) Structural systems
GB9720633D0 (en) BHV-2 vector
GB2331752B (en) Vectors
GB9624457D0 (en) Retroviral vectors
PL322145A1 (en) Shaped structural member
PL318601A1 (en) Novel 5-arylidene-4-oxo-2-imidazpglycines
HK1024718A (en) Crossless retroviral vectors
GB9608328D0 (en) Improved retroviral vectors
GB2350613B (en) Vectors
GB9719593D0 (en) Coating system
GB9702215D0 (en) Novel product
GB9702216D0 (en) Novel product